Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Location
Boston, MA
Fiscal year end
26 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 742% % -36%
Debt-to-equity 22% % 44%
Return On Equity -83% % -58%
Return On Assets -68% % -49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,596,407 shares -88%
Common Stock, Shares, Outstanding 9,586,770 shares 86%
Entity Public Float $50,500,000 USD -40%
Common Stock, Value, Issued $10,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 6,891,336 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 6,891,336 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $99,127,000 USD -0.2%
General and Administrative Expense $22,987,000 USD -19%
Operating Income (Loss) $122,114,000 USD 4.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $116,803,000 USD 0.27%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $116,803,000 USD 0.27%
Earnings Per Share, Basic -16.95 USD/shares 21%
Earnings Per Share, Diluted -16.95 USD/shares 21%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $38,918,000 USD -31%
Other Assets, Current $320,000 USD -57%
Assets, Current $160,926,000 USD -11%
Property, Plant and Equipment, Net $16,532,000 USD -27%
Operating Lease, Right-of-Use Asset $10,927,000 USD -23%
Other Assets, Noncurrent $76,000 USD -82%
Assets $192,355,000 USD -13%
Accounts Payable, Current $4,739,000 USD -1.9%
Employee-related Liabilities, Current $5,632,000 USD -21%
Liabilities, Current $21,531,000 USD 11%
Operating Lease, Liability, Noncurrent $10,910,000 USD -23%
Other Liabilities, Noncurrent $62,000 USD -47%
Liabilities $33,145,000 USD -1.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $102,000 USD 538%
Retained Earnings (Accumulated Deficit) $614,697,000 USD -23%
Stockholders' Equity Attributable to Parent $159,210,000 USD -15%
Liabilities and Equity $192,355,000 USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,397,000 USD -11%
Net Cash Provided by (Used in) Financing Activities $104,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $2,861,000 USD -1097%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 9,586,770 shares 86%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $28,362,000 USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41,790,000 USD -30%
Deferred Tax Assets, Valuation Allowance $140,532,000 USD 18%
Deferred Tax Assets, Gross $143,134,000 USD 17%
Operating Lease, Liability $13,747,000 USD -20%
Depreciation $6,381,000 USD -1.3%
Payments to Acquire Property, Plant, and Equipment $1,492,000 USD 524%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $116,717,000 USD 0.33%
Lessee, Operating Lease, Liability, to be Paid $16,099,000 USD -22%
Property, Plant and Equipment, Gross $43,919,000 USD 0.18%
Operating Lease, Liability, Current $2,837,000 USD -9.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,352,000 USD -33%
Deferred Tax Assets, Operating Loss Carryforwards $103,031,000 USD 38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $32,104,000 USD 22%
Operating Lease, Payments $900,000 USD -40%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,602,000 USD -13%
Share-based Payment Arrangement, Expense $14,267,000 USD -36%
Interest Expense $36,000 USD 800%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%